Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Classical hematology 1

Conditions

Thrombocytopenia 1Neutropenia 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Leukemia 1Anemia 1

Interventions

Cytarabine 56Etoposide 24Daunorubicin 22Filgrastim 18Busulfan 16fludarabine phosphate 14Mitoxantrone 14Idarubicin 14Cyclophosphamide 14Peripheral Blood Stem Cell Transplantation 12tipifarnib 11Gemtuzumab 11Flow Cytometry 9Cyclosporine 9Antilymphocyte Serum 9sargramostim 8Methotrexate 8Clofarabine 8Gene Expression Profiling 7Topotecan 6Radiotherapy 6Azacitidine 6valspodar 5alvocidib 5aldesleukin 5Melphalan 5Whole-Body Irradiation 4Observation 4Methylprednisolone 4Granulocyte Colony-Stimulating Factor 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Erythroblastic, Acute × leridistim × Clear all
NCT00004215 2013-06-19

Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
Classical hematologyOther hematologic neoplasm

Anemia, Leukemia, Erythroblastic, Acute, Leukemia, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Neutropenia, Thrombocytopenia, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡